5. Modification of proteins during aging

Facts, Research and Intervention in Geriatrics

Volumn 2000, Issue PART 1, 2000, Pages 75-94

  Levine, R L ^a   Stadtman, E R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442420084     PISSN: 12824038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Agarwal S and Sohal RS (1994) Aging and proteolysis of oxidized proteins. Archives of Biochemistry and Biophysics 309:24-28.
2. Ames BN, Shigenaga MK, and Hagen TM (1993) Oxidants, antioxidants, and the degenerative disease of aging. Proceedings of the National Academy of Sciences of the United States of America 90:7915-7922.
3. Biemann K (1992) Mass spectrometry of peptides and proteins. Annual Review of Biochemistry 61:977-1010.
4. Brownlee M, Vlassara H, Kooney A, Ulrich P, and Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632.
5. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, and Vlassara H (1994) Modifications of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proceedings of the National Academy of Sciences of the United States of America 91:9441-9445.
6. Carney JM, Starke-Reed PE, Oliver CN, Landrum RW, Cheng MS, Wu JF, and Floyd RA (1991) Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-(-phenylnitrone. Proceedings of the National Academy of Sciences of the United States of America 88:3633-3636.
7. De la Cruz CP, Revilla E, Venero JL, Ayala A, Cano J, and Machado A (1996) Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat. Free Radical Biology and Medicine 20:53-61.
8. Dean RT, Gieseg S, and Davies MJ (1993) Reactive species and their accumulation on radical-damaged proteins. Trends in Biochemical Sciences 18:437-441.
9. Esterbauer H, Schaur RJ, and Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 11:81-128.
10. Farber JM and Levine RL (1986) Sequence of a peptide susceptible to mixed function oxidation: Probable cation binding site in glutamine synthetase. Journal of Biological Chemistry 261:4574-4578.
11. Friguet B, Stadtman ER, and Szweda LI (1994) Modificaton of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal: Formation of cross-linked protein which inhigits the multicatalytic protease. Journal of Biological Chemistry 269:21639-21643.
12. Fucci L, Oliver CN, Coon MJ, and Stadtman ER (1983) Inactivation of key metabolic enzymes by mixed-function oxidation reactions: Possible implication in protein turnover and ageing. Proceedings of the National Academy of Sciences of the United States ot America 80:1521-1525.
13. Garland D (1990) Role of site-specific, metal-catalyzed oxidation in lens-aging and cataract: a hypothesis. Experimental Eye Research 50:677-682.
14. Giulivi C and Davies KJA (1993) Dityrosine and tyrosine oxidation products are endogenous markers for selective proteolysis of oxidatively modified red blood cell hemoglobin by the 19S proteasome. Journal of Biological Chemistry 268:8752-8759.
15. Gordillo E, Ayala A, F-Lobato M, Bautista J, and Machado A (1988) Possible involvement of histidine residues in the loss of enzymatic activity of rat liver malic enzyme during aging. Journal of Biological Chemistry 263:8053-8057.
16. Grant AJ, Jessup W, and Dean RT (1992) Accelerated endocytosis and incomplete catabolism of radical damaged protein. Biochemica Biophysica Acta 1134:203-209.
17. Grant AJ, Jessup W, and Dean RT (1993) Inefficient degradation of oxidized regions of protein molecules. Free Radical research Communications 18:259-267.
18. Ivy GO, Ihara Y, and Kitani K (1991) The protease inhibitor leupeptin induces several signs of aging in brain, retina and internal organs of young rats. Archives of Gerontology and Geriatrics 12:119-131.
19. Ivy GO, Schottler F, Wenzel J, Baudry M, and Lynch G (1984) Inhibitors of lysosomal enzymes: Accumulation of lipofuscin-like dense bodies in the brain. Science 226:985-987.
20. Jurgens G, Lang J, and Esterbauer H (1986) Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochemica Biophysica Acta 875:103-114.
21. Kim K, Kim I-H, Lee K-Y, Rhee SG, and Stadtman ER (1988) The isolation and purification of a specific "protector" protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system. Journal of Biological Chemistry 263:4704-4711.
22. Kristal BS, and Yu BP (1992) An emerging hypothesis: Synergistic induction of aging by free radicals and Maillard reactions. Journal of Gerontology Biological Sciences 47:B107-B114.
23. Lee AT, and Cerami A (1990) Modifications of proteins and nucleic acids by reducing sugars: Possible role in aging. In: E.L. Schneider and J.W. Rowe (Eds.) Handbook of the Biology of Aging, (pp. 116-130) San Diego: Academic Press.
24. Levine RL (1989) Proteolysis induced by metal-catalyzed oxidation. Cell Biology Reviews 21:347-360.
25. Levine RL and Stadtman ER (1996) Protein modification with aging. In: EL Schneider and JW Rowe (Eds.) Handbook of the Biology of Aging, (pp.184-197). San Diego: Academic Press.
26. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, and Bucala R (1992) Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258:651-653.
27. Mehlhorn I, Groth D, Stockel J, Moffat B, Reilly D, Yansura D, Willett WS, Baldwin M, Fletterick R, Cohen FE, Vandlen R, Henner D, and Prusiner SB (1996) High-level expression and characterization of a purified 143-residue polypeptide of the prion protein. Biochemistry 35(17):5528-5537.
28. Monnier V (1990) Nonenzymatic glycosylation, the Maillard reaction, and the aging process. Journal of Gerontology Biological Sciences 45:B105-B111.
29. Musci G, di Path MCB, Fagiolo U, and Calabrese L (1993) Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. Journal of Biological Chemistry 268:13388-13395.
30. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, and Stadtman ER (1987) Age-related changes in oxidized proteins. Journal of Biological Chemistry 262:5488-5491.
31. Oliver CN, Fulks R, Levine RL, Fucci L, Rivett AJ, Roseman JE, and Stadtman ER (1984) Oxidative inactivation of key metabolic enzymes during aging. In: AK Ray and B Chatterjee (Eds.) Molecular Basis of Aging (pp.235-262) New York: Academic Press.
32. Pacifici RE, Salo DC, and Davies KJA (1989) Macroxyproteinase (M.O.P.): A 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radical Biology and Medicine 7:521-536.
33. Rivett AJ (1985) The effect of mixed-function oxidation of enzymes on their susceptibility to degradation by a nonlysosomal cysteine proteinase. Archives of Biochemistry and Biophysics 243:624-632.
34. Rivett AJ (1986) Regulation of intracellular protein turnover: Covalent modification as a mechanisms of marking proteins for regulation. Current Topics in Cellular Regulation 28:291-337.
35. Rivett AJ and Levine RL (1990) Metal-catalyzed oxidation of Escherichia coli glutamine synthetase: Correlation of structural and funcational changes. Archives of Biochemistry and Biophysics 278:26-34.
36. Rothstein M (1984) Changes in enzymatic proteins during aging. In: AK Roy and B Chatterjee (Eds.), Molecular Basis of Aging (pp.209-232). New York: Academic Press.
37. Sahakian JA, Szweda LI, Friguet B, Kitani K, and Levine RL (1995) Aging of the liver: Proteolysis of oxidatively modified glutamine synthetase. Archives of Biochemistry and Biophysics, 318:411-417.
38. Santa Maria C, Revilla E, Ayala A, de la Cruz CP, and Machado A (1995) Changes in the histidine residues of Cu/Zn superoxide dismutase during aging. FEBS Letters 374:85-88.
39. Shacter E, Williams JA, Lim M, and Levine RL (1994) Differential susceptibility of plasma proteins to oxidative modification: Examination by Western blot immunoassay. Free Radical Biology and Medicine 17:429-437.
40. Sierra F, Coeytaux S, Juillerat M, Ruffieux C, Gauldie J, and Guigoz Y (1992) Serum T-kininogen levels increase two to four months before death. Journal of Biological Chemistry 267:10665-106659.
41. Smith CD, Carney JM, Starke-Reed PE, Oliver Cn, Stadtman ER, Floyd RA, and Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 88:10540-10543.
42. Sohal RS, Agarwal S, Dubey A, and Orr WC (1993) Protein oxidative damage is associated with life expectancy of houseflies. Proceedings of the National Academy of Sciences of the United States of America 90:7255-7259.
43. Stadtman ER (1988) Protein modification in aging. Journal of Gerontology Biological Sciences 43:B112-B120.
44. Stadtman ER (1990) Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences. Free Radical Biology and Medicine 9:315-325.
45. Stadtman ER (1992) Protein oxidation and aging. Science 257:1220-1224.
46. Stadtman ER (1995) Role of oxidized amino acids in protein breakdown and stability. Methods in Enzymology 258:379-393.
47. Stadtman ER and Oliver CN (1991) Metal-catalyzed oxidation of proteins. Physiological consequences. Journal of Biological Chemistry 266:2005-2008.
48. Starke-Reed PE and Oliver CN (1989) Protein oxidation and proteolysis during aging and oxidative stress. Archives of Biochemistry and Biophysics 275:559-567.
49. Uchida K and Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. A possible involvement of intra-and intermolecular cross-linking reaction. Journal of Biological Chemistry 268:6388-6393.
50. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, and Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 91:4766-4770.
51. Vlassara H (1994) Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 124:19-30.
52. Wells-Knecht MC, Huggins TG, Dyer DC, Thorpe SR, and Baynes JW (1993) Oxidized amino acids in lens protein with age. Measurement of o-tyrosine and dityrosine in aging human lens. Journal of Biological Chemistry 269:12348-12352.
53. Wolff SP, Jiang ZY and Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biology and Medicine 10:339-352.